Biomarkers in psoriatic arthritis

a systematic literature review

Elena Generali, Carlo A. Scirè, Ennio G. Favalli, Carlo Selmi

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

ABSTRACT: Psoriatic arthritis (PsA) is characterized by chronic inflammation of peripheral joints and axial skeleton, associated with a strong genetic background. Clinics include enthesitis or dactylitis and extra-articular involvement as uveitis or inflammatory bowel disease, while treatment options range from nonsteroidal anti-inflammatory drugs (NSAIDs) to biologics, targeting TNF α or Th17. No serum autoantibody is associated with PsA, while other biomarkers have been proposed for early diagnosis or to predict treatment response. To better discuss this area of growing interest we performed a systematic review of the literature on biomarkers in PsA. Our research retrieved 408 papers, and 38 were included in the analysis. Based on the available literature, we draw some recommendations for the use of biomarkers in the management of patients with PsA.

Original languageEnglish (US)
Pages (from-to)651-660
Number of pages10
JournalExpert Review of Clinical Immunology
Volume12
Issue number6
DOIs
StatePublished - Jun 2 2016
Externally publishedYes

Fingerprint

Psoriatic Arthritis
Biomarkers
Joints
Uveitis
Biological Products
Inflammatory Bowel Diseases
Skeleton
Autoantibodies
Early Diagnosis
Anti-Inflammatory Agents
Inflammation
Therapeutics
Serum
Research
Pharmaceutical Preparations

Keywords

  • autoantibodies
  • biologics
  • genetics
  • personalized medicine
  • Psoriasis
  • spondyloarthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Biomarkers in psoriatic arthritis : a systematic literature review. / Generali, Elena; Scirè, Carlo A.; Favalli, Ennio G.; Selmi, Carlo.

In: Expert Review of Clinical Immunology, Vol. 12, No. 6, 02.06.2016, p. 651-660.

Research output: Contribution to journalReview article

Generali, Elena ; Scirè, Carlo A. ; Favalli, Ennio G. ; Selmi, Carlo. / Biomarkers in psoriatic arthritis : a systematic literature review. In: Expert Review of Clinical Immunology. 2016 ; Vol. 12, No. 6. pp. 651-660.
@article{88e517bc643c449c954ec30b50064880,
title = "Biomarkers in psoriatic arthritis: a systematic literature review",
abstract = "ABSTRACT: Psoriatic arthritis (PsA) is characterized by chronic inflammation of peripheral joints and axial skeleton, associated with a strong genetic background. Clinics include enthesitis or dactylitis and extra-articular involvement as uveitis or inflammatory bowel disease, while treatment options range from nonsteroidal anti-inflammatory drugs (NSAIDs) to biologics, targeting TNF α or Th17. No serum autoantibody is associated with PsA, while other biomarkers have been proposed for early diagnosis or to predict treatment response. To better discuss this area of growing interest we performed a systematic review of the literature on biomarkers in PsA. Our research retrieved 408 papers, and 38 were included in the analysis. Based on the available literature, we draw some recommendations for the use of biomarkers in the management of patients with PsA.",
keywords = "autoantibodies, biologics, genetics, personalized medicine, Psoriasis, spondyloarthritis",
author = "Elena Generali and Scir{\`e}, {Carlo A.} and Favalli, {Ennio G.} and Carlo Selmi",
year = "2016",
month = "6",
day = "2",
doi = "10.1586/1744666X.2016.1147954",
language = "English (US)",
volume = "12",
pages = "651--660",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Biomarkers in psoriatic arthritis

T2 - a systematic literature review

AU - Generali, Elena

AU - Scirè, Carlo A.

AU - Favalli, Ennio G.

AU - Selmi, Carlo

PY - 2016/6/2

Y1 - 2016/6/2

N2 - ABSTRACT: Psoriatic arthritis (PsA) is characterized by chronic inflammation of peripheral joints and axial skeleton, associated with a strong genetic background. Clinics include enthesitis or dactylitis and extra-articular involvement as uveitis or inflammatory bowel disease, while treatment options range from nonsteroidal anti-inflammatory drugs (NSAIDs) to biologics, targeting TNF α or Th17. No serum autoantibody is associated with PsA, while other biomarkers have been proposed for early diagnosis or to predict treatment response. To better discuss this area of growing interest we performed a systematic review of the literature on biomarkers in PsA. Our research retrieved 408 papers, and 38 were included in the analysis. Based on the available literature, we draw some recommendations for the use of biomarkers in the management of patients with PsA.

AB - ABSTRACT: Psoriatic arthritis (PsA) is characterized by chronic inflammation of peripheral joints and axial skeleton, associated with a strong genetic background. Clinics include enthesitis or dactylitis and extra-articular involvement as uveitis or inflammatory bowel disease, while treatment options range from nonsteroidal anti-inflammatory drugs (NSAIDs) to biologics, targeting TNF α or Th17. No serum autoantibody is associated with PsA, while other biomarkers have been proposed for early diagnosis or to predict treatment response. To better discuss this area of growing interest we performed a systematic review of the literature on biomarkers in PsA. Our research retrieved 408 papers, and 38 were included in the analysis. Based on the available literature, we draw some recommendations for the use of biomarkers in the management of patients with PsA.

KW - autoantibodies

KW - biologics

KW - genetics

KW - personalized medicine

KW - Psoriasis

KW - spondyloarthritis

UR - http://www.scopus.com/inward/record.url?scp=84959063180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959063180&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2016.1147954

DO - 10.1586/1744666X.2016.1147954

M3 - Review article

VL - 12

SP - 651

EP - 660

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 6

ER -